Home / Posts Tagged "Covaxin"

According to the sources, Bharat Biotech which has completed the Phase 2/3 trials of Covid-19 vaccine Covaxin for use in children under 18 years of age has submitted the data to the Central Drugs Standard Control Organisation for its verification and subsequent approval for Emergency Use Authorisation

READ MORE

In a study of 614 fully vaccinated health workers in India discovered a "significant" drop in their COVID-fighting antibodies within four months of the first shot. This findings might help the Indian government to decide whether to provide booster doses. Some of the Western countries have done. The director

READ MORE

Covid-19 in India may be entering some kind of stage of endemicity where there is low or moderate level of transmission going on, Chief Scientist of the World Health Organisation Dr Soumya Swaminathan said. The endemic stage is when a population learns to live with a

READ MORE

Union health minister Mansukh Mandaviya on Thursday said the government has launched an inquiry into a report claiming that counterfeit versions of Covishield, India’s primary anti-COVID-19 vaccine, had been seized. “It has been claimed that duplicate versions of Covishield vaccine were sold in the country. The

READ MORE

India’s Covaxin, developed by Bharat Biotech in collaboration with the Indian Council of Medical Research, effectively neutralises both Alpha and Delta variants of coronavirus, the US’ National Institute of Health has said. The NIH said results of two studies of blood serum from people who

READ MORE

The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday. There was no dissenting voice among the members of the National Technical Advisory Group on Immunization (NTAGI

READ MORE

The recruitment for the clinical trial of the country’s first indigenously-developed COVID-19 vaccine, Covaxin, among children in the age group of 6-12 years will begin at the AIIMS here from Tuesday. This will be followed by the clinical trial of children in the age-group of 2-6

READ MORE